Surgery Partners, Inc. (NASDAQ:SGRY) Receives Consensus Rating of “Moderate Buy” from Analysts

Surgery Partners, Inc. (NASDAQ:SGRY) has earned a consensus recommendation of “Moderate Buy” from the nine brokerages that are currently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 12-month target price among brokers that have covered the stock in the last year is $36.63.

A number of research firms recently weighed in on SGRY. Royal Bank of Canada restated an “outperform” rating and issued a $35.00 target price on shares of Surgery Partners in a report on Tuesday. JPMorgan Chase & Co. lowered their price objective on Surgery Partners from $38.00 to $28.00 and set a “neutral” rating for the company in a research note on Tuesday, December 3rd. Macquarie dropped their target price on Surgery Partners from $34.00 to $33.00 and set an “outperform” rating on the stock in a report on Tuesday, March 11th. Finally, Bank of America assumed coverage on Surgery Partners in a report on Monday, December 16th. They set a “buy” rating and a $30.00 price target for the company.

Insider Buying and Selling

In related news, CEO Jason Eric Evans sold 26,520 shares of the stock in a transaction dated Friday, February 7th. The shares were sold at an average price of $25.65, for a total transaction of $680,238.00. Following the completion of the transaction, the chief executive officer now owns 560,698 shares in the company, valued at approximately $14,381,903.70. This represents a 4.52 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO David T. Doherty sold 13,641 shares of the business’s stock in a transaction dated Friday, February 7th. The shares were sold at an average price of $25.61, for a total transaction of $349,346.01. Following the completion of the transaction, the chief financial officer now owns 108,862 shares in the company, valued at approximately $2,787,955.82. The trade was a 11.14 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 106,622 shares of company stock worth $2,717,860. 2.30% of the stock is owned by company insiders.

Institutional Investors Weigh In On Surgery Partners

Hedge funds have recently modified their holdings of the stock. Point72 Asia Singapore Pte. Ltd. increased its stake in shares of Surgery Partners by 747.6% in the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 3,831 shares of the company’s stock worth $124,000 after purchasing an additional 3,379 shares in the last quarter. KBC Group NV lifted its holdings in Surgery Partners by 66.1% during the 4th quarter. KBC Group NV now owns 3,962 shares of the company’s stock worth $84,000 after purchasing an additional 1,577 shares in the last quarter. State of Wyoming boosted its stake in Surgery Partners by 94.4% in the 4th quarter. State of Wyoming now owns 4,002 shares of the company’s stock worth $85,000 after purchasing an additional 1,943 shares during the period. MeadowBrook Investment Advisors LLC grew its holdings in Surgery Partners by 16.6% during the 4th quarter. MeadowBrook Investment Advisors LLC now owns 10,280 shares of the company’s stock valued at $218,000 after buying an additional 1,460 shares in the last quarter. Finally, Tower Research Capital LLC TRC increased its position in shares of Surgery Partners by 279.3% during the fourth quarter. Tower Research Capital LLC TRC now owns 10,762 shares of the company’s stock valued at $228,000 after buying an additional 7,925 shares during the period.

Surgery Partners Stock Down 0.7 %

Shares of NASDAQ:SGRY opened at $23.95 on Monday. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80. Surgery Partners has a 52-week low of $19.50 and a 52-week high of $33.97. The business’s 50 day simple moving average is $24.31 and its two-hundred day simple moving average is $25.59. The firm has a market cap of $3.06 billion, a P/E ratio of -49.90, a PEG ratio of 19.21 and a beta of 2.73.

Surgery Partners (NASDAQ:SGRY) last issued its earnings results on Monday, March 3rd. The company reported $0.39 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.38 by $0.01. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The company had revenue of $864.40 million for the quarter, compared to analysts’ expectations of $828.09 million. As a group, research analysts forecast that Surgery Partners will post 0.67 EPS for the current fiscal year.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.